Will there be a successful human trial of a vaccine for rheumatoid arthritis by the end of 2028?
Santé et médecineOne-Off2a
Manifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleNon 79.8%
Prévisionnistes
3
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 11 heures
Obsolète22 mai 23, 01:52 UTC1 janv. 29, 04:59 UTC
Tendances
Règles
A team of researchers from the University of Toledo report that they were able to suppress the development of rheumatoid arthritis in rats by administering a vaccine containing the protein 14-3-3 zeta:
- https://www.thebrighterside.news/post/life-changing-vaccine-provides-long-lasting-protection-against-rheumatoid-arthritis
- The researchers have apparently filed for a patent for this concept and intend to pursue approval for early clinical trials in humans.
- Will their findings be reproduced in human trials?
- This will resolve YES if any clinical trial is performed to evaluate the efficacy of a vaccine for rheumatoid arthritis based on 14-3-3ζ before the end date, and the trial results show a statistically significant effect.
- Resolves NO otherwise.
